These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 14681703)
1. Molecular strategies for improving cytokine transgene expression in normal and malignant tissues. Yang NS; Wang JH; Turner J Gene Ther; 2004 Jan; 11(1):100-8. PubMed ID: 14681703 [TBL] [Abstract][Full Text] [Related]
2. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside. O'Malley BW; Li D; McQuone SJ; Ralston R Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147 [TBL] [Abstract][Full Text] [Related]
3. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter. Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Yamamoto M; Alvarez RD; Curiel DT Gene Ther; 2004 Apr; 11(7):645-8. PubMed ID: 15029227 [TBL] [Abstract][Full Text] [Related]
5. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ. Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779 [TBL] [Abstract][Full Text] [Related]
6. Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate. Hofbauer GF; Baur T; Bonnet MC; Tartour E; Burg G; Berinstein NL; Dummer R Melanoma Res; 2008 Apr; 18(2):104-11. PubMed ID: 18337646 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy. Stagg J; Wu JH; Bouganim N; Galipeau J Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter. Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620 [TBL] [Abstract][Full Text] [Related]
10. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine]. Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159 [TBL] [Abstract][Full Text] [Related]
11. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery. Wooddell CI; Reppen T; Wolff JA; Herweijer H J Gene Med; 2008 May; 10(5):551-63. PubMed ID: 18330848 [TBL] [Abstract][Full Text] [Related]
12. Cytokine-based therapy for melanoma: pre-clinical studies. Shurin MR; Kirkwood JM; Esche C Forum (Genova); 2000; 10(3):204-26. PubMed ID: 11007930 [TBL] [Abstract][Full Text] [Related]
13. Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: successful treatment of oral melanoma and distant skin lesion. Wang J; Murakami T; Hakamata Y; Ajiki T; Jinbu Y; Akasaka Y; Ohtsuki M; Nakagawa H; Kobayashi E Cancer Gene Ther; 2001 Oct; 8(10):705-12. PubMed ID: 11687893 [TBL] [Abstract][Full Text] [Related]
14. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology. Simons JW; Mikhak B Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681 [TBL] [Abstract][Full Text] [Related]
15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
16. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha. Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961 [TBL] [Abstract][Full Text] [Related]
17. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers. Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771 [TBL] [Abstract][Full Text] [Related]
18. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model. Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915 [TBL] [Abstract][Full Text] [Related]
19. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells. Shi CX; Long MA; Liu L; Graham FL; Gauldie J; Hitt MM Mol Ther; 2004 Oct; 10(4):758-67. PubMed ID: 15451460 [TBL] [Abstract][Full Text] [Related]
20. Vaccination with helper-dependent adenovirus enhances the generation of transgene-specific CTL. Harui A; Roth MD; Kiertscher SM; Mitani K; Basak SK Gene Ther; 2004 Nov; 11(22):1617-26. PubMed ID: 15295617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]